Cytosorbents Finalizes 1-for-20 Reverse Split Effective September 8
CTSO is trading near its 52-week low of $6 (14% above the low).
Summary
Cytosorbents executed a 1-for-20 reverse stock split effective September 8, 2026, reducing outstanding shares from 63.0M to approximately 3.15M to address Nasdaq listing requirements.
Key Events · Corporate Governance and Compliance · CTSO
-
1-for-20 Reverse Split Effective
Every 20 shares of common stock were reclassified into 1 share, effective 12:01 a.m. ET on September 8, 2026. Pre-split outstanding shares were 63,022,020, resulting in approximately 3,151,101 post-split shares.
-
Nasdaq Compliance Effort
The reverse split is the final step in addressing the Nasdaq minimum market value notice received on July 6, 2026. Trading continues on a split-adjusted basis under the new CUSIP 23283X305.
-
No Change to Authorized Shares
The reverse split did not change the total number of authorized shares. Outstanding options and warrants were proportionately adjusted with corresponding exercise price changes.
-
Financial Distress Context
The split follows a Q2 2026 10-Q showing a $9.5M H1 net loss, a going concern warning, and only $4.4M in unrestricted cash. The split addresses listing compliance but not the underlying cash runway.
Analysis · CTSO · Industrial Applications And Services
The board selected the maximum 1-for-20 ratio from the shareholder-approved range, reducing the outstanding share count from 63,022,020 to approximately 3,151,101 shares. This is the final step in the company's effort to regain Nasdaq compliance after receiving a minimum market value notice in July. The reverse split mechanically boosts the per-share price but does not change the company's market capitalization or its underlying financial challenges — a $9.5M H1 net loss, going concern warning, and only $4.4M in unrestricted cash as of the last 10-Q.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTSO was trading at $6.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $441.3M. The 52-week trading range was $6.00 to $20.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.